Michael Roach

2.6k total citations · 2 hit papers
70 papers, 1.7k citations indexed

About

Michael Roach is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiation. According to data from OpenAlex, Michael Roach has authored 70 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pulmonary and Respiratory Medicine, 26 papers in Oncology and 26 papers in Radiation. Recurrent topics in Michael Roach's work include Lung Cancer Diagnosis and Treatment (31 papers), Advanced Radiotherapy Techniques (26 papers) and Lung Cancer Treatments and Mutations (14 papers). Michael Roach is often cited by papers focused on Lung Cancer Diagnosis and Treatment (31 papers), Advanced Radiotherapy Techniques (26 papers) and Lung Cancer Treatments and Mutations (14 papers). Michael Roach collaborates with scholars based in United States, Canada and Netherlands. Michael Roach's co-authors include Clifford G. Robinson, Jeffrey D. Bradley, Parag J. Parikh, Lauren E. Henke, Jeffrey R. Olsen, Soumon Rudra, T.A. DeWees, J. Contreras, Gregory M.M. Videtic and Jeffrey D. Bradley and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and CHEST Journal.

In The Last Decade

Michael Roach

64 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline

2017 299 citations Gregory M.M. Videtic, Jessica Donington et al. Practical Radiation Oncology profile →
Using adaptive magnetic resonance image‐guided radiation therapy for treatment of inoperable pancreatic cancer

2019 237 citations Soumon Rudra, Jeffrey R. Olsen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Roach United States	18	1.0k	828	815	443	183	70	1.7k
Thomas J. Dilling United States	20	1.1k 1.1×	784 0.9×	563 0.7×	430 1.0×	152 0.8×	84	1.7k
Ruggero Ruggieri Italy	26	1.1k 1.1×	645 0.8×	1.1k 1.3×	240 0.5×	218 1.2×	96	1.7k
Marco Trovò Italy	21	1.3k 1.3×	738 0.9×	665 0.8×	554 1.3×	243 1.3×	88	2.0k
Gerard G. Hanna United Kingdom	21	986 0.9×	909 1.1×	740 0.9×	341 0.8×	157 0.9×	107	1.7k
Andrew Warner Canada	23	1.4k 1.3×	565 0.7×	614 0.8×	415 0.9×	263 1.4×	102	1.8k
Brian Yaremko Canada	24	1.3k 1.2×	827 1.0×	831 1.0×	406 0.9×	428 2.3×	79	2.0k
Takuyo Kozuka Japan	17	1.1k 1.1×	484 0.6×	595 0.7×	272 0.6×	291 1.6×	67	1.6k
Kayoko Tsujino Japan	21	1.3k 1.2×	733 0.9×	570 0.7×	452 1.0×	323 1.8×	72	1.9k
J. Petersen Denmark	19	981 0.9×	599 0.7×	901 1.1×	254 0.6×	214 1.2×	48	1.6k
M.C. Dobelbower United States	17	1.0k 1.0×	599 0.7×	677 0.8×	297 0.7×	143 0.8×	57	1.5k

Countries citing papers authored by Michael Roach

Since Specialization

Citations

This map shows the geographic impact of Michael Roach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Roach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Roach more than expected).

Fields of papers citing papers by Michael Roach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Roach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Roach. The network helps show where Michael Roach may publish in the future.

Co-authorship network of co-authors of Michael Roach

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Roach. A scholar is included among the top collaborators of Michael Roach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Roach. Michael Roach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Corace, Kim, Kednapa Thavorn, Kelly D. Suschinsky, et al.. (2023). Rapid Access Addiction Medicine Clinics for People With Problematic Opioid Use. JAMA Network Open. 6(11). e2344528–e2344528. 4 indexed citations

Contreras, J., Pamela Samson, T.A. DeWees, et al.. (2022). Phase I Study of Accelerated Hypofractionated Proton Therapy and Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 113(4). 742–748. 11 indexed citations

Henke, Lauren E., Benjamin W. Fischer‐Valuck, Soumon Rudra, et al.. (2022). Prospective imaging comparison of anatomic delineation with rapid kV cone beam CT on a novel ring gantry radiotherapy device. Radiotherapy and Oncology. 178. 109428–109428. 13 indexed citations

Rudra, Soumon, Amit Roy, Randall Brenneman, et al.. (2020). Radiation-Induced Brachial Plexopathy in Patients With Breast Cancer Treated With Comprehensive Adjuvant Radiation Therapy. Advances in Radiation Oncology. 6(1). 100602–100602. 11 indexed citations

Hassanzadeh, Comron, Timothy L. Sita, Pamela Samson, et al.. (2020). Implications of pneumonitis after chemoradiation and durvalumab for locally advanced non-small cell lung cancer. Journal of Thoracic Disease. 12(11). 6690–6700. 23 indexed citations

Hassanzadeh, Comron, Soumon Rudra, William G. Hawkins, et al.. (2020). Ablative Five-Fraction Stereotactic Body Radiation Therapy for Inoperable Pancreatic Cancer Using Online MR-Guided Adaptation. Advances in Radiation Oncology. 6(1). 100506–100506. 90 indexed citations

Sita, Timothy L., Comron Hassanzadeh, Pamela Samson, et al.. (2019). OA03.03 Multi-Institutional Study of Pneumonitis After Treatment with Durvalumab and Chemoradiotherapy for Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 14(11). S1131–S1132. 2 indexed citations

Juloori, Aditya, Alexander Zajichek, Michael W. Kattan, et al.. (2018). An Externally Validated Nomogram for Predicting Distant Metastasis after Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: Implications for Adjuvant Systemic Therapy. International Journal of Radiation Oncology*Biology*Physics. 102(3). S11–S11. 1 indexed citations

Juloori, Aditya, Alexander Zajichek, Michael W. Kattan, et al.. (2018). MA01.03 An Externally Validated Nomogram for Predicting Distant Metastasis After SBRT for Early Stage Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 13(10). S354–S355. 1 indexed citations

10.

DeWees, T.A., et al.. (2018). Stereotactic Body Radiotherapy for Early-Stage Multiple Primary Lung Cancers. Clinical Lung Cancer. 20(2). 107–116. 20 indexed citations

11.

Henke, Lauren E., J. Contreras, Bin Cai, et al.. (2018). Magnetic Resonance Image-Guided Radiotherapy (MRIgRT): A 4.5-Year Clinical Experience. Clinical Oncology. 30(11). 720–727. 99 indexed citations

12.

Contreras, J., Alexander J. Lin, Ashley Weiner, et al.. (2018). Cardiac dose is associated with immunosuppression and poor survival in locally advanced non-small cell lung cancer. Radiotherapy and Oncology. 128(3). 498–504. 73 indexed citations

13.

Green, Olga, Lauren E. Henke, Parag J. Parikh, et al.. (2018). Practical Implications of Ferromagnetic Artifacts in Low-field MRI-guided Radiotherapy. Cureus. 10(3). e2359–e2359. 5 indexed citations

14.

Contreras, J., Anupama Chundury, Francisco J. Reynoso, et al.. (2017). Proton Therapy Reirradiation for Thoracic Recurrences: Toxicity and Outcomes. International Journal of Radiation Oncology*Biology*Physics. 99(2). E448–E448. 1 indexed citations

15.

Videtic, Gregory M.M., Jessica Donington, Meredith Giuliani, et al.. (2017). Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline. Practical Radiation Oncology. 7(5). 295–301. 299 indexed citations breakdown →

16.

Higgins, Kristin, Jenny K. Hoang, Michael Roach, et al.. (2011). Analysis of Pretreatment FDG-PET SUV Parameters in Head-and-Neck Cancer: Tumor SUVmean Has Superior Prognostic Value. International Journal of Radiation Oncology*Biology*Physics. 82(2). 548–553. 107 indexed citations

17.

Roach, Michael, Timothy G. Turkington, Kristin Higgins, et al.. (2010). FDG-PET Assessment of the Effect of Head and Neck Radiotherapy on Parotid Gland Glucose Metabolism. International Journal of Radiation Oncology*Biology*Physics. 82(1). 321–326. 19 indexed citations

18.

Roach, Michael, et al.. (2010). Treatment of Unicentric Castleman Disease With Neoadjuvant Rituximab. CHEST Journal. 138(5). 1239–1241. 29 indexed citations

19.

Yarbrough, Wendell G., Amy S. Whigham, Brandee Brown, Michael Roach, & Robbert J.C. Slebos. (2007). Phosphoinositide Kinase-3 Status Associated With Presence or Absence of Human Papillomavirus in Head and Neck Squamous Cell Carcinomas. International Journal of Radiation Oncology*Biology*Physics. 69(2). S98–S101. 17 indexed citations

20.

Perez, Carlos A., John C. Blasko, J.D. Forman, et al.. (2000). Definitive external beam irradiation in stage T1 and T2 carcinoma of the prostate. American College of Radiology. ACR Appropriateness Criteria.. PubMed. 215 Suppl. 1449–72. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact